nodes	percent_of_prediction	percent_of_DWPC	metapath
Procaine—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0311	0.11	CbGpPWpGaD
Procaine—BCHE—diaphragm—chronic obstructive pulmonary disease	0.0277	0.467	CbGeAlD
Procaine—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0265	0.0936	CbGpPWpGaD
Procaine—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0254	0.0896	CbGpPWpGaD
Procaine—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0247	0.0873	CbGpPWpGaD
Procaine—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.0219	0.0772	CbGpPWpGaD
Procaine—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0216	0.0763	CbGpPWpGaD
Procaine—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0202	0.0711	CbGpPWpGaD
Procaine—Respiratory arrest—Aminophylline—chronic obstructive pulmonary disease	0.0184	0.0284	CcSEcCtD
Procaine—Arachnoiditis—Prednisolone—chronic obstructive pulmonary disease	0.0183	0.0282	CcSEcCtD
Procaine—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.0178	0.0629	CbGpPWpGaD
Procaine—Excitement—Aminophylline—chronic obstructive pulmonary disease	0.0165	0.0255	CcSEcCtD
Procaine—Respiratory arrest—Formoterol—chronic obstructive pulmonary disease	0.014	0.0216	CcSEcCtD
Procaine—Respiratory arrest—Arformoterol—chronic obstructive pulmonary disease	0.014	0.0216	CcSEcCtD
Procaine—Arachnoiditis—Prednisone—chronic obstructive pulmonary disease	0.0133	0.0205	CcSEcCtD
Procaine—Excitement—Salbutamol—chronic obstructive pulmonary disease	0.0119	0.0183	CcSEcCtD
Procaine—Ventricular arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.011	0.0169	CcSEcCtD
Procaine—Block heart—Formoterol—chronic obstructive pulmonary disease	0.0109	0.0167	CcSEcCtD
Procaine—Block heart—Arformoterol—chronic obstructive pulmonary disease	0.0109	0.0167	CcSEcCtD
Procaine—Paralysis—Formoterol—chronic obstructive pulmonary disease	0.00889	0.0137	CcSEcCtD
Procaine—Paralysis—Arformoterol—chronic obstructive pulmonary disease	0.00889	0.0137	CcSEcCtD
Procaine—HTR3A—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00807	0.0285	CbGpPWpGaD
Procaine—HTR3A—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00719	0.0254	CbGpPWpGaD
Procaine—Vasodilation—Salbutamol—chronic obstructive pulmonary disease	0.00664	0.0102	CcSEcCtD
Procaine—Vasodilation procedure—Salbutamol—chronic obstructive pulmonary disease	0.00664	0.0102	CcSEcCtD
Procaine—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.00658	0.0101	CcSEcCtD
Procaine—Atrioventricular block—Formoterol—chronic obstructive pulmonary disease	0.00637	0.00979	CcSEcCtD
Procaine—Atrioventricular block—Arformoterol—chronic obstructive pulmonary disease	0.00637	0.00979	CcSEcCtD
Procaine—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00624	0.0096	CcSEcCtD
Procaine—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.00609	0.00936	CcSEcCtD
Procaine—HTR3A—respiratory system—chronic obstructive pulmonary disease	0.0057	0.0962	CbGeAlD
Procaine—Neuropathy—Montelukast—chronic obstructive pulmonary disease	0.00568	0.00874	CcSEcCtD
Procaine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00522	0.00803	CcSEcCtD
Procaine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00517	0.00795	CcSEcCtD
Procaine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00498	0.00767	CcSEcCtD
Procaine—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.00491	0.00755	CcSEcCtD
Procaine—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00486	0.00748	CcSEcCtD
Procaine—SLC6A3—respiratory system—chronic obstructive pulmonary disease	0.00475	0.08	CbGeAlD
Procaine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00451	0.00694	CcSEcCtD
Procaine—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00395	0.00608	CcSEcCtD
Procaine—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00376	0.00578	CcSEcCtD
Procaine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00374	0.00576	CcSEcCtD
Procaine—SLC6A3—Monoamine Transport—SLC6A4—chronic obstructive pulmonary disease	0.0037	0.0131	CbGpPWpGaD
Procaine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—chronic obstructive pulmonary disease	0.00357	0.0126	CbGpPWpGaD
Procaine—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.00356	0.00548	CcSEcCtD
Procaine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00348	0.00536	CcSEcCtD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00346	0.0122	CbGpPWpGaD
Procaine—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00345	0.00531	CcSEcCtD
Procaine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00345	0.0053	CcSEcCtD
Procaine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00338	0.00521	CcSEcCtD
Procaine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00332	0.00511	CcSEcCtD
Procaine—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.00332	0.0051	CcSEcCtD
Procaine—SCN10A—lung—chronic obstructive pulmonary disease	0.00327	0.0551	CbGeAlD
Procaine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00326	0.00502	CcSEcCtD
Procaine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00326	0.00501	CcSEcCtD
Procaine—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.0032	0.00492	CcSEcCtD
Procaine—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.0032	0.00492	CcSEcCtD
Procaine—BCHE—respiratory system—chronic obstructive pulmonary disease	0.00316	0.0534	CbGeAlD
Procaine—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00315	0.00485	CcSEcCtD
Procaine—Neuropathy—Prednisolone—chronic obstructive pulmonary disease	0.00314	0.00483	CcSEcCtD
Procaine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00307	0.00473	CcSEcCtD
Procaine—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00306	0.0047	CcSEcCtD
Procaine—Clomifene—CYP1A1—chronic obstructive pulmonary disease	0.00304	0.407	CrCbGaD
Procaine—HTR3A—lung—chronic obstructive pulmonary disease	0.00303	0.0511	CbGeAlD
Procaine—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00302	0.00465	CcSEcCtD
Procaine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00301	0.00463	CcSEcCtD
Procaine—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.003	0.00462	CcSEcCtD
Procaine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00297	0.00457	CcSEcCtD
Procaine—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00294	0.00452	CcSEcCtD
Procaine—Clomifene—CYP1A2—chronic obstructive pulmonary disease	0.00293	0.392	CrCbGaD
Procaine—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00289	0.00445	CcSEcCtD
Procaine—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00289	0.00444	CcSEcCtD
Procaine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00287	0.00442	CcSEcCtD
Procaine—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00285	0.00438	CcSEcCtD
Procaine—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00285	0.00438	CcSEcCtD
Procaine—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00283	0.00435	CcSEcCtD
Procaine—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00282	0.00997	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00281	0.00991	CbGpPWpGaD
Procaine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00276	0.00425	CcSEcCtD
Procaine—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00274	0.00421	CcSEcCtD
Procaine—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00273	0.00421	CcSEcCtD
Procaine—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00273	0.0042	CcSEcCtD
Procaine—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00273	0.0042	CcSEcCtD
Procaine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00271	0.00416	CcSEcCtD
Procaine—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00269	0.00413	CcSEcCtD
Procaine—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00266	0.0041	CcSEcCtD
Procaine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00265	0.00408	CcSEcCtD
Procaine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00265	0.00408	CcSEcCtD
Procaine—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00263	0.00404	CcSEcCtD
Procaine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00262	0.00403	CcSEcCtD
Procaine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00262	0.00403	CcSEcCtD
Procaine—BCHE—bronchus—chronic obstructive pulmonary disease	0.0026	0.0439	CbGeAlD
Procaine—CHRNA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.0026	0.00919	CbGpPWpGaD
Procaine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00258	0.00397	CcSEcCtD
Procaine—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	0.00255	0.043	CbGeAlD
Procaine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00253	0.00389	CcSEcCtD
Procaine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00253	0.00389	CcSEcCtD
Procaine—SLC6A3—lung—chronic obstructive pulmonary disease	0.00252	0.0425	CbGeAlD
Procaine—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00251	0.00386	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.0025	0.00883	CbGpPWpGaD
Procaine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.0025	0.00385	CcSEcCtD
Procaine—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00249	0.00383	CcSEcCtD
Procaine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00248	0.00382	CcSEcCtD
Procaine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00248	0.00382	CcSEcCtD
Procaine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00248	0.00381	CcSEcCtD
Procaine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00248	0.00381	CcSEcCtD
Procaine—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00247	0.0038	CcSEcCtD
Procaine—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00247	0.0038	CcSEcCtD
Procaine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00243	0.00374	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00243	0.00858	CbGpPWpGaD
Procaine—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00242	0.00372	CcSEcCtD
Procaine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00239	0.00367	CcSEcCtD
Procaine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00234	0.0036	CcSEcCtD
Procaine—BCHE—trachea—chronic obstructive pulmonary disease	0.00234	0.0394	CbGeAlD
Procaine—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00233	0.00359	CcSEcCtD
Procaine—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00233	0.00359	CcSEcCtD
Procaine—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00233	0.00358	CcSEcCtD
Procaine—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00231	0.00355	CcSEcCtD
Procaine—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.0023	0.00354	CcSEcCtD
Procaine—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.0023	0.00354	CcSEcCtD
Procaine—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.0023	0.00354	CcSEcCtD
Procaine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00229	0.00352	CcSEcCtD
Procaine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00229	0.00352	CcSEcCtD
Procaine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00229	0.00352	CcSEcCtD
Procaine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00229	0.00352	CcSEcCtD
Procaine—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00229	0.00352	CcSEcCtD
Procaine—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.00228	0.00351	CcSEcCtD
Procaine—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00225	0.00346	CcSEcCtD
Procaine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00224	0.00345	CcSEcCtD
Procaine—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00224	0.00345	CcSEcCtD
Procaine—Oedema—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00339	CcSEcCtD
Procaine—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00339	CcSEcCtD
Procaine—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00339	CcSEcCtD
Procaine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00339	CcSEcCtD
Procaine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.0022	0.00339	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00219	0.00774	CbGpPWpGaD
Procaine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00217	0.00334	CcSEcCtD
Procaine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00217	0.00334	CcSEcCtD
Procaine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00216	0.00333	CcSEcCtD
Procaine—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00216	0.00332	CcSEcCtD
Procaine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00216	0.00332	CcSEcCtD
Procaine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00215	0.00331	CcSEcCtD
Procaine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00215	0.00331	CcSEcCtD
Procaine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00213	0.00328	CcSEcCtD
Procaine—CHRNA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00212	0.00749	CbGpPWpGaD
Procaine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00211	0.00325	CcSEcCtD
Procaine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00208	0.0032	CcSEcCtD
Procaine—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00208	0.0032	CcSEcCtD
Procaine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00206	0.00317	CcSEcCtD
Procaine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00206	0.00317	CcSEcCtD
Procaine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00205	0.00315	CcSEcCtD
Procaine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00205	0.00315	CcSEcCtD
Procaine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00204	0.00314	CcSEcCtD
Procaine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00203	0.00312	CcSEcCtD
Procaine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00201	0.00309	CcSEcCtD
Procaine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.00309	CcSEcCtD
Procaine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00201	0.00309	CcSEcCtD
Procaine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00201	0.00309	CcSEcCtD
Procaine—CHRNA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.002	0.00704	CbGpPWpGaD
Procaine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00198	0.00305	CcSEcCtD
Procaine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00197	0.00302	CcSEcCtD
Procaine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00196	0.00301	CcSEcCtD
Procaine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00196	0.00301	CcSEcCtD
Procaine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00299	CcSEcCtD
Procaine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00193	0.00297	CcSEcCtD
Procaine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00192	0.00295	CcSEcCtD
Procaine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00191	0.00295	CcSEcCtD
Procaine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00292	CcSEcCtD
Procaine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00292	CcSEcCtD
Procaine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.0019	0.00292	CcSEcCtD
Procaine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00186	0.00286	CcSEcCtD
Procaine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00185	0.00285	CcSEcCtD
Procaine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00184	0.00283	CcSEcCtD
Procaine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00183	0.00282	CcSEcCtD
Procaine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00183	0.00281	CcSEcCtD
Procaine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00182	0.00281	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00181	0.0064	CbGpPWpGaD
Procaine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00181	0.00278	CcSEcCtD
Procaine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00276	CcSEcCtD
Procaine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00175	0.00269	CcSEcCtD
Procaine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00175	0.00269	CcSEcCtD
Procaine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00174	0.00268	CcSEcCtD
Procaine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00174	0.00268	CcSEcCtD
Procaine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00174	0.00267	CcSEcCtD
Procaine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00172	0.00265	CcSEcCtD
Procaine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00172	0.00265	CcSEcCtD
Procaine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00172	0.00265	CcSEcCtD
Procaine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00171	0.00264	CcSEcCtD
Procaine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00171	0.00263	CcSEcCtD
Procaine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00171	0.00262	CcSEcCtD
Procaine—BCHE—lung—chronic obstructive pulmonary disease	0.00168	0.0283	CbGeAlD
Procaine—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00168	0.00258	CcSEcCtD
Procaine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.00254	CcSEcCtD
Procaine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00164	0.00253	CcSEcCtD
Procaine—CHRNA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00163	0.00574	CbGpPWpGaD
Procaine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00162	0.0025	CcSEcCtD
Procaine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00162	0.0025	CcSEcCtD
Procaine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00162	0.00249	CcSEcCtD
Procaine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00159	0.00245	CcSEcCtD
Procaine—BCHE—Peptide hormone metabolism—ACE—chronic obstructive pulmonary disease	0.00158	0.00559	CbGpPWpGaD
Procaine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00156	0.0024	CcSEcCtD
Procaine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.0024	CcSEcCtD
Procaine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.00236	CcSEcCtD
Procaine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00153	0.00235	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00152	0.00537	CbGpPWpGaD
Procaine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00232	CcSEcCtD
Procaine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00232	CcSEcCtD
Procaine—Probenecid—ALB—chronic obstructive pulmonary disease	0.00151	0.201	CrCbGaD
Procaine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00149	0.00229	CcSEcCtD
Procaine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00227	CcSEcCtD
Procaine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00226	CcSEcCtD
Procaine—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00146	0.00225	CcSEcCtD
Procaine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00224	CcSEcCtD
Procaine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00224	CcSEcCtD
Procaine—BCHE—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00144	0.00507	CbGpPWpGaD
Procaine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00143	0.0022	CcSEcCtD
Procaine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00219	CcSEcCtD
Procaine—SLC6A3—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00141	0.00498	CbGpPWpGaD
Procaine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00216	CcSEcCtD
Procaine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00216	CcSEcCtD
Procaine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00214	CcSEcCtD
Procaine—Rash—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00214	CcSEcCtD
Procaine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00214	CcSEcCtD
Procaine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00214	CcSEcCtD
Procaine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00138	0.00212	CcSEcCtD
Procaine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00212	CcSEcCtD
Procaine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00211	CcSEcCtD
Procaine—Rash—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00209	CcSEcCtD
Procaine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00209	CcSEcCtD
Procaine—SLC6A3—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.00135	0.00475	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00134	0.00475	CbGpPWpGaD
Procaine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00134	0.00206	CcSEcCtD
Procaine—SLC6A3—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00133	0.00471	CbGpPWpGaD
Procaine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00205	CcSEcCtD
Procaine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00204	CcSEcCtD
Procaine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00202	CcSEcCtD
Procaine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00131	0.00202	CcSEcCtD
Procaine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00202	CcSEcCtD
Procaine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00201	CcSEcCtD
Procaine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00201	CcSEcCtD
Procaine—SLC6A3—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.00129	0.00456	CbGpPWpGaD
Procaine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00128	0.00198	CcSEcCtD
Procaine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00197	CcSEcCtD
Procaine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00195	CcSEcCtD
Procaine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00194	CcSEcCtD
Procaine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00191	CcSEcCtD
Procaine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.0019	CcSEcCtD
Procaine—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00121	0.00187	CcSEcCtD
Procaine—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00184	CcSEcCtD
Procaine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00184	CcSEcCtD
Procaine—SLC6A3—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00119	0.0042	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.00118	0.00417	CbGpPWpGaD
Procaine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00181	CcSEcCtD
Procaine—BCHE—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00117	0.00413	CbGpPWpGaD
Procaine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00116	0.00179	CcSEcCtD
Procaine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.00177	CcSEcCtD
Procaine—SLC6A3—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00115	0.00406	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.00112	0.00396	CbGpPWpGaD
Procaine—SLC6A3—Dopaminergic Neurogenesis—TGFB1—chronic obstructive pulmonary disease	0.0011	0.00389	CbGpPWpGaD
Procaine—BCHE—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.0011	0.00389	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.0011	0.00388	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00108	0.00381	CbGpPWpGaD
Procaine—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00163	CcSEcCtD
Procaine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.001	0.00154	CcSEcCtD
Procaine—BCHE—Peptide hormone metabolism—LEP—chronic obstructive pulmonary disease	0.000984	0.00348	CbGpPWpGaD
Procaine—SLC6A3—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.000977	0.00345	CbGpPWpGaD
Procaine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000976	0.0015	CcSEcCtD
Procaine—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000971	0.00149	CcSEcCtD
Procaine—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000953	0.00147	CcSEcCtD
Procaine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000948	0.00146	CcSEcCtD
Procaine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000934	0.00144	CcSEcCtD
Procaine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00092	0.00142	CcSEcCtD
Procaine—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000917	0.00141	CcSEcCtD
Procaine—SCN10A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.000911	0.00322	CbGpPWpGaD
Procaine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000904	0.00139	CcSEcCtD
Procaine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000901	0.00139	CcSEcCtD
Procaine—BCHE—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000897	0.00317	CbGpPWpGaD
Procaine—SLC6A3—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000881	0.00311	CbGpPWpGaD
Procaine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000879	0.00135	CcSEcCtD
Procaine—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000867	0.00133	CcSEcCtD
Procaine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000867	0.00133	CcSEcCtD
Procaine—Shock—Prednisone—chronic obstructive pulmonary disease	0.000853	0.00131	CcSEcCtD
Procaine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000846	0.0013	CcSEcCtD
Procaine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000838	0.00129	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000831	0.00293	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000829	0.00293	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000818	0.00289	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000814	0.00287	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000797	0.00281	CbGpPWpGaD
Procaine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00079	0.00122	CcSEcCtD
Procaine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000789	0.00121	CcSEcCtD
Procaine—BCHE—Metabolism of proteins—MUC5AC—chronic obstructive pulmonary disease	0.000763	0.0027	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000762	0.00269	CbGpPWpGaD
Procaine—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000752	0.00116	CcSEcCtD
Procaine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000752	0.00116	CcSEcCtD
Procaine—BCHE—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000751	0.00265	CbGpPWpGaD
Procaine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000748	0.00115	CcSEcCtD
Procaine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000709	0.00109	CcSEcCtD
Procaine—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000689	0.00106	CcSEcCtD
Procaine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000685	0.00105	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000675	0.00238	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—MUC1—chronic obstructive pulmonary disease	0.000649	0.00229	CbGpPWpGaD
Procaine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000639	0.000983	CcSEcCtD
Procaine—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000613	0.000944	CcSEcCtD
Procaine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000593	0.000913	CcSEcCtD
Procaine—HTR3A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000578	0.00204	CbGpPWpGaD
Procaine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000573	0.000882	CcSEcCtD
Procaine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000551	0.000848	CcSEcCtD
Procaine—HTR3A—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000551	0.00194	CbGpPWpGaD
Procaine—Rash—Prednisone—chronic obstructive pulmonary disease	0.000547	0.000841	CcSEcCtD
Procaine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000546	0.00084	CcSEcCtD
Procaine—BCHE—Metabolism—APIP—chronic obstructive pulmonary disease	0.000519	0.00183	CbGpPWpGaD
Procaine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000515	0.000792	CcSEcCtD
Procaine—SCN10A—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000506	0.00179	CbGpPWpGaD
Procaine—HTR3A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000467	0.00165	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000426	0.0015	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000383	0.00135	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.00037	0.00131	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000344	0.00122	CbGpPWpGaD
Procaine—BCHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000344	0.00121	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000341	0.0012	CbGpPWpGaD
Procaine—BCHE—Metabolism—GC—chronic obstructive pulmonary disease	0.000335	0.00118	CbGpPWpGaD
Procaine—HTR3A—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000331	0.00117	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000311	0.0011	CbGpPWpGaD
Procaine—SLC6A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000311	0.0011	CbGpPWpGaD
Procaine—SLC6A3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000309	0.00109	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.000304	0.00107	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	0.000299	0.00106	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000273	0.000964	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	0.000269	0.000949	CbGpPWpGaD
Procaine—SCN10A—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000265	0.000934	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000262	0.000924	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000251	0.000885	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000248	0.000875	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000246	0.000867	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000234	0.000826	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000192	0.000678	CbGpPWpGaD
Procaine—SCN10A—Developmental Biology—IL6—chronic obstructive pulmonary disease	0.000189	0.000667	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000186	0.000656	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000183	0.000645	CbGpPWpGaD
Procaine—BCHE—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000181	0.000638	CbGpPWpGaD
Procaine—BCHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000168	0.000595	CbGpPWpGaD
Procaine—BCHE—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000165	0.000582	CbGpPWpGaD
Procaine—SLC6A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000157	0.000555	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.000536	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000127	0.000447	CbGpPWpGaD
Procaine—BCHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000125	0.000441	CbGpPWpGaD
Procaine—BCHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000124	0.000436	CbGpPWpGaD
Procaine—BCHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000116	0.000411	CbGpPWpGaD
Procaine—BCHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.00039	CbGpPWpGaD
Procaine—BCHE—Metabolism—ALB—chronic obstructive pulmonary disease	7.5e-05	0.000265	CbGpPWpGaD
Procaine—BCHE—Metabolism—NOS3—chronic obstructive pulmonary disease	7.18e-05	0.000253	CbGpPWpGaD
